Committed to transforming
the treatment of severe, chronic
autoimmune diseases.

Committed to transforming
the treatment of severe, chronic
autoimmune diseases.

Bedoret, Denis

  • Photo:
  • First name: Denis
  • Surname: Bedoret
  • Position: Chief Executive Officer
  • Contact:

    E info@imcyse.com

Denis Bedoret joined Imcyse in September 2020 as Chief Executive Officer. Prior to joining Imcyse, Denis was Chief Executive Officer at MaSTherCell SA, Belgium and President of MaSTherCell Global Inc., U.S. for four years. Under his leadership, the Company expanded significantly growing from 60 to 260 employees and positioning as a leader in the field of CDMO’s dedicated to Cell and Gene therapies products. Catalent Pharma Solutions, Inc. acquired MaSTherCell and Denis managed the transition period. Prior to his position at MaSTherCell, Denis held the position of Chief Operations Officer at Quality Assistance S.A. a leading European analytical CRO where he was also a member of the Board of Directors. Before that, Denis served as engagement manager at McKinsey & Company, focusing on life science projects. Through these experiences, Denis has gained strong expertise in the global development of innovative human medical products with a focus on biologicals as well as in corporate strategy development and implementation. Denis holds a degree in Veterinary Medicine, a Ph.D. in Life Sciences from the University of Liège and a postdoc in Immunology from Harvard Medical School.

Management, Directors

  • Hits: 4719

©imcyse 2023